North Star Investment Management’s Epizyme, Inc EPZM Stock Holding History

North Star Investment Management’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-15,000	Closed	-$22K	–	1204
2022 Q2	$22K	Hold	15,000	–	–	﹤0.01%	698
2022 Q1	$17K	Hold	15,000	–	–	﹤0.01%	775
2021 Q4	$38K	Sell	15,000 -6,200	-29%	-$24.4K	﹤0.01%	675
2021 Q3	$109K	Buy	21,200 +1,000	+5%	+$6.07K	0.01%	463
2021 Q2	$168K	Hold	20,200	–	–	0.01%	407
2021 Q1	$176K	Sell	20,200 -119,600	-86%	-$1.24M	0.02%	376
2020 Q4	$1.52M	Buy	139,800 +21,400	+18%	+$264K	0.16%	151
2020 Q3	$1.41M	Buy	118,400 +19,800	+20%	+$265K	0.17%	135
2020 Q2	$1.58M	Buy	98,600 +41,100	+71%	+$717K	0.21%	116
2020 Q1	$892K	Buy	57,500 +35,900	+166%	+$771K	0.13%	171
2019 Q4	$531K	Buy	+21,600	New	+$321K	0.06%	262

Other funds holding EPZM

Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

North Star Investment Management's EPZM Position: Q3 2022 in Review

North Star Investment Management sold out of Epizyme, Inc (EPZM) in Q3 2022, closing a stake of 15,000 shares — an estimated $22K sold.

North Star Investment Management first reported a position in EPZM in Q4 2019 and held it in 11 quarters. The position peaked at $1.58M in Q2 2020. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.

North Star Investment Management reported no remaining Epizyme, Inc position as of Q3 2022 after selling out during the quarter.
North Star Investment Management sold 15,000 Epizyme, Inc shares in Q3 2022, an estimated $22K.
North Star Investment Management first reported a position in Epizyme, Inc in Q4 2019 and held it in 11 quarters.
North Star Investment Management's Epizyme, Inc position peaked at $1.58M in Q2 2020.
0 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2022.

Based on North Star Investment Management's 13F filing for Q3 2022, filed 2 Nov 2022.